バイオ技術向け培地、血清、試薬の世界市場

Report Highlights

The global market for media, sera and reagents in biotechnology is expected to grow from $6.3 billion in 2024 and is projected to reach $9.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2024 to 2029.

バイオ技術向け培地、血清、試薬の世界市場は、2024年の63億ドルから2024年から2029年の予測期間中に8.1%の複合年間成長率（CAGR）で成長し、2029年末までに93億ドルに達すると予測されています。

Report Scope

This report highlights current and future market potential for media, sera and reagents in biotechnology. It provides a detailed analysis of the market drivers, restraints and opportunities. The report includes detailed information on emerging technologies, patent analysis, ESG development, investment outlook and deals. The report also covers market projections through 2029 and presents a competitive landscape. The report provides market estimates and forecasts based on product type, end user and region. The market is segmented by product type into reagents, media and sera. The reagents market is segmented into reagents: biological response modifiers, cell dissociation reagents and others (amino acids, antibiotics, etc.). Market analysis in the media segment is divided into specialty and classical media based on composition. The media are divided into powdered and ready-to-use liquid media based on formulation. Based on serum components, media are segmented into serum-free and serum-requiring media. The market for sera is segmented based on the source of serum into fetal bovine serum and other sera, including from animal sources such as goats, porcine, rabbits, etc. By end user, the market is segmented into biopharmaceutical companies, academic research institutes, contract research organizations and others. The report includes profiles of the key companies with detailed information about their business segments, financials, product portfolios and recent developments.

The market is segregated by geographical region into North America, Europe, Asia-Pacific and the Rest of the World. The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea and the Rest of Asia-Pacific. For market estimates, data is provided for 2021 and 2022 as the historical years, 2023 as the base year and 2029 as the forecast year.

Report Synopsis

Report Includes

– 87 data tables and 55 additional tables

– An analysis of the global market for media, sera and reagents in the biotech industry

– Analyses of the global market trends, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029

– Evaluation of the overall market size for media, sera and reagents and their corresponding market share analysis by product type, end use and region

– Discussion of the market potential, and forecasts for the market’s segments and sub-segments

– In-depth information concerning market drivers, opportunities, challenges and other demographic and economic factors that will drive demand for media, sera and reagents

– Review of the current market status, key technology issues, industry value chain, Porter’s Five Forces, competitive landscape and R&D activity

– A discussion of the industry’s ESG challenges and practices

– Market share analysis of the key companies in the industry and coverage of their proprietary technologies, strategic alliances, and other market strategies

– Profiles of the leading companies

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Insights

Chapter 2 Market Overview

Introduction

Types of Cell Culture

Primary Culture

Secondary Culture

Basic Components of Culture Media

Buffering Systems

Phenol Red

Inorganic Salts

Amino Acids

Carbohydrates

Proteins and Peptides

Fatty Acids and Lipids

Vitamins

Trace Elements

Media Supplements

Antibiotics

Serum

Cell Culture Applications

Chapter 3 Market Dynamics

Market Dynamics Snapshot

Market Drivers

Rising Investments in Biopharmaceuticals

Increasing Demand for Personalized Medicines

Technological Advances

Rising Aging Population and the Growing Prevalence of Chronic Diseases

Market Restraints

Ethical Issues and Regulatory Constraints

Lack of Skilled Professionals and High Cost of Biopharmaceutical Development

Market Opportunities

Rising Demand for 3D Cell Cultures

Rising Demand for Biopharmaceuticals in Emerging Countries

Chapter 4 Emerging Technologies

Introduction

Emerging Technologies

Application of AI/ML in Cell Culture

Single Use Technologies

Patent Analysis

Cell Culture Media

Cell Culture Reagents

Chapter 5 Regulatory Scenario

Regulatory Landscape in the Global Market

Cell Culture Media

Sera

Chapter 6 Market Segmentation Analysis

Global Market Insights

Segmentation Breakdown

Market Analysis by Product Type

Reagents

Media

Sera

Market Analysis by End User

Biopharmaceutical Companies

Academic Research Institutes

Contract Manufacturing and Development Organizations (CDMOs/CROs)

Other End Users

Geographic Breakdown

Market Analysis by Region

North America

Europe

Asia-Pacific

Rest of the World (RoW)

Chapter 7 Competitive Intelligence

Overview

Market Rankings Analysis

Strategic Initiatives

M&A Activities

Investments and Expansions

Product Introductions

Chapter 8 Sustainability in the Media, Sera and Reagents in Biotechnology Market: An ESG Perspective

Introduction to ESG

ESG Sustainability Trends and Initiatives

Environmental Initiatives

Social and Governance Initiatives

Governance Initiatives

ESG Risk Ratings Analysis

Concluding Remarks from BCC

Chapter 9 Appendix

Methodology

Sources

Abbreviations

Company Profiles

ATCC

BD

BIO-TECHNE

BIOWEST

CORNING INC.

DANAHER CORP.

FUJIFILM IRVINE SCIENTIFIC

LONZA

MERCK KGAA

MILTENYI BIOTEC

PROMOCELL GMBH

REPROCELL INC.

SARTORIUS AG

STEMCELL TECHNOLOGIES

THERMO FISHER SCIENTIFIC INC.

List of Tables

Summary Table : Global Market for Media, Sera and Reagents in Biotechnology, by Region, Through 2029

Table 1 : Primary Versus Continuous Cell Lines

Table 2 : Medicines in Development, by Select Disease Category, 2020

Table 3 : Incidence and Mortality Rates of Cancer Across Regions, 2022

Table 4 : Global Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 5 : Global Market for Cell Culture Reagents, by Reagent Type, Through 2029

Table 6 : Global Market for Cell Culture Reagents, by Region, Through 2029

Table 7 : Global Market for Cell Culture Media, by Region, Through 2029

Table 8 : Global Market for Cell Culture Media, by Sera, Through 2029

Table 9 : Global Market for Cell Culture Media, by Formulation, Through 2029

Table 10 : Global Market for Cell Culture Media, by Composition, Through 2029

Table 11 : Global Market for Cell Culture Sera, by Region, Through 2029

Table 12 : Global Market for Cell Culture Sera, by Type, Through 2029

Table 13 : Global Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 14 : Global Market for Media, Sera and Reagents Use in Biopharmaceutical Companies, by Region, Through 2029

Table 15 : Global Market for Media, Sera and Reagents Use in Academic Research Institutes, by Region, Through 2029

Table 16 : Global Market for Media, Sera and Reagents Use in CDMOs/CROs, by Region, Through 2029

Table 17 : Global Market for Media, Sera and Reagents in Other End Uses, by Region, Through 2029

Table 18 : Global Market for Media, Sera and Reagents in Biotechnology, by Region, Through 2029

Table 19 : North American Market for Media, Sera and Reagents in Biotechnology, by Country, Through 2029

Table 20 : North American Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 21 : North American Market for Cell Culture Reagents, by Reagent Type, Through 2029

Table 22 : North American Market for Cell Culture Media, by Sera, Through 2029

Table 23 : North American Market for Cell Culture Media, by Formulation, Through 2029

Table 24 : North American Market for Cell Culture Media, by Composition, Through 2029

Table 25 : North American Market for Cell Culture Sera, by Type, Through 2029

Table 26 : North American Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 27 : The U.S. Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 28 : The U.S. Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 29 : Canadian Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 30 : Canadian Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 31 : Mexican Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 32 : Mexican Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 33 : European-Based Companies’ R&D Expenditures and Comparison of Their Net Sales, 2023

Table 34 : European Market for Media, Sera and Reagents in Biotechnology, by Country, Through 2029

Table 35 : European Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 36 : European Market for Cell Culture Reagents, by Reagent Type, Through 2029

Table 37 : European Market for Cell Culture Media, by Sera, Through 2029

Table 38 : European Market for Cell Culture Media, by Formulation, Through 2029

Table 39 : European Market for Cell Culture Media, by Composition, Through 2029

Table 40 : European Market for Cell Culture Sera, by Type, Through 2029

Table 41 : European Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 42 : German Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 43 : German Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 44 : French Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 45 : French Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 46 : Italian Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 47 : Italian Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 48 : Spanish Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 49 : Spanish Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 50 : The U.K. Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 51 : The U.K. Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 52 : Rest of European Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 53 : Rest of European Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 54 : Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, by Country, Through 2029

Table 55 : Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 56 : Asia-Pacific Market for Cell Culture Reagents, by Reagent Type, Through 2029

Table 57 : Asia-Pacific Market for Cell Culture Media, by Sera, Through 2029

Table 58 : Asia-Pacific Market for Cell Culture Media, by Formulation, Through 2029

Table 59 : Asia-Pacific Market for Cell Culture Media, by Composition, Through 2029

Table 60 : Asia-Pacific Market for Cell Culture Sera, by Type, Through 2029

Table 61 : Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 62 : Chinese Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 63 : Chinese Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 64 : Japanese Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 65 : Japanese Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 66 : Indian Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 67 : Indian Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 68 : South Korean Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 69 : South Korean Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 70 : Rest of Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 71 : Rest of Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 72 : RoW Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029

Table 73 : RoW Market for Cell Culture Reagents, by Reagent Type, Through 2029

Table 74 : RoW Market for Cell Culture Media, by Sera, Through 2029

Table 75 : RoW Market for Cell Culture Media, by Formulation, Through 2029

Table 76 : RoW Market for Cell Culture Media, by Composition, Through 2029

Table 77 : RoW Market for Cell Culture Sera, by Type, Through 2029

Table 78 : RoW Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029

Table 79 : Global Ranking of Manufacturers in Media, Sera and Reagents Market, 2023

Table 80 : Partnerships, Agreements and Collaborations in Media, Sera and Reagents in the Biotechnology Industry, 2021-2025

Table 81 : Merger and Acquisition Activities in Media, Sera and Reagents in the Biotechnology Market, 2022-2024

Table 82 : Recent Investment and Expansion Activities in Media, Sera and Reagents in the Biotechnology Market, 2022–2024

Table 83 : Recent Product Innovations in the Cell Culture Media, Sera and Reagents Market, 2021–2024

Table 84 : Environmental Initiatives by Various Suppliers of Media, Sera and Reagents in the Biotechnology Market

Table 85 : Key Social and Governance Issues in the Media, Sera and Reagents Biotechnology Market

Table 86 : ESG Risk Ratings for Companies in the Media, Sera and Reagents Market, 2023

Table 87 : Information Sources for this Report

Table 88 : Abbreviations Used in the Media, Sera and Reagents in Biotechnology Market

Table 89 : ATCC: Company Snapshot

Table 90 : ATCC: Product Portfolio

Table 91 : ATCC: News/Key Developments, 2023 and 2024

Table 92 : BD: Company Snapshot

Table 93 : BD: Financial Performance, FY 2023 and 2024

Table 94 : BD: Product Portfolio

Table 95 : BD: News/Key Developments, 2022-2024

Table 96 : Bio-Techne: Company Snapshot

Table 97 : Bio-Techne: Financial Performance, FY 2022 and 2023

Table 98 : Bio-Techne: Product Portfolio

Table 99 : Bio-Techne: News/Key Developments, 2021-2024

Table 100 : Biowest.: Company Snapshot

Table 101 : Biowest: Product Portfolio

Table 102 : Corning Inc.: Company Snapshot

Table 103 : Corning Inc.: Financial Performance, FY 2022 and 2023

Table 104 : Corning Inc.: Product Portfolio

Table 105 : Corning Inc.: News/Key Developments, 2022 and 2023

Table 106 : Danaher Corp.: Company Snapshot

Table 107 : Danaher Corp.: Financial Performance, FY 2022 and 2023

Table 108 : Danaher Corp.: Product Portfolio

Table 109 : Danaher Corp.: News/Key Developments, 2021-2023

Table 110 : Fujifilm Irvine Scientific: Company Snapshot

Table 111 : Fujifilm Irvine Scientific: Product Portfolio

Table 112 : Fujifilm Irvine Scientific: News/Key Developments, 2022-2024

Table 113 : Lonza: Company Snapshot

Table 114 : Lonza: Financial Performance, FY 2022 and 2023

Table 115 : Lonza: Product Portfolio

Table 116 : Lonza: News/Key Developments, 2023 and 2024

Table 117 : Merck KGaA: Company Snapshot

Table 118 : Merck KGaA: Financial Performance, FY 2022 and 2023

Table 119 : Merck KGaA.: Product Portfolio

Table 120 : Merck KGaA: News/Key Developments, 2021-2025

Table 121 : Miltenyi Biotec: Company Snapshot

Table 122 : Miltenyi Biotec: Product Portfolio

Table 123 : Miltenyi Biotec: News/Key Developments, 2023 and 2024

Table 124 : PromoCell GmbH.: Company Snapshot

Table 125 : PromoCell GmbH.: Product Portfolio

Table 126 : PromoCell GmbH.: News/Key Developments, 2023 and 2024

Table 127 : REPROCELL Inc.: Company Snapshot

Table 128 : REPROCELL Inc.: Financial Performance, FY 2022 and 2023

Table 129 : REPROCELL Inc.: Product Portfolio

Table 130 : REPROCELL Inc.: News/Key Developments, 2021-2025

Table 131 : Sartorius AG: Company Snapshot

Table 132 : Sartorius AG: Financial Performance, FY 2022 and 2023

Table 133 : Sartorius AG: Product Portfolio

Table 134 : Sartorius AG: News/Key Developments, 2023 and 2024

Table 135 : STEMCELL Technologies: Company Snapshot

Table 136 : STEMCELL Technologies: Product Portfolio

Table 137 : STEMCELL Technologies: News/Key Developments, 2021-2024

Table 138 : Thermo Fisher Scientific Inc.: Company Snapshot

Table 139 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023

Table 140 : Thermo Fisher Scientific Inc.: Product Portfolio

Table 141 : Thermo Fisher Scientific Inc.: News/Key Developments, 2021-2024

List of Figures

Summary Figure : Global Market for Media, Sera and Reagents in Biotechnology, by Region, 2021-2029

Figure 1 : Cell Culture Timeline

Figure 2 : Market Dynamics of Global Media, Sera and Reagents in Biotechnology

Figure 3 : Venture Averages for Biopharma Therapeutics and Platform Companies, 2010–2024

Figure 4 : Personalized Medicines’ Contribution to the Total FDA Approvals, 2015–2023

Figure 5 : Patents Documented on Cell Culture Media, by Top Applicants, 2021–January, 2025

Figure 6 : Share of Patents on Cell Culture Media, by Patent Jurisdiction, 2021–January 2025

Figure 7 : Patents Documented on Cell Culture Media Over Time, 2010–January 2025

Figure 8 : Patents Documented on Cell Culture Reagents, by Top Applicants, 2021–January 2025

Figure 9 : Share of Patents on Cell Culture Reagents, by Jurisdiction, 2021–January 2025

Figure 10 : Patents Documented on Cell Culture Reagents Over Time, 2010–January 2025

Figure 11 : Global Market Shares of Media, Sera and Reagents in Biotechnology, by Product Type, 2023

Figure 12 : Global Market Shares of Cell Culture Reagents, by Reagent Type, 2023

Figure 13 : Global Market Shares of Cell Culture Media, by Sera, 2023

Figure 14 : Global Market Shares of Cell Culture Media, by Formulation, 2023

Figure 15 : Global Market Shares of Cell Culture Media, by Composition, 2023

Figure 16 : Global Market Shares of Cell Culture Sera, by Type, 2023

Figure 17 : Global Market Shares of Media, Sera and Reagents in Biotechnology, by End User, 2023

Figure 18 : Global Market Shares of Media, Sera and Reagents in Biotechnology, by Region, 2023

Figure 19 : North American Market Shares of Media, Sera and Reagents in Biotechnology, by Country, 2023

Figure 20 : The U.S. NIH Funding in Healthcare Research and Development Activities, 2010–2023

Figure 21 : Number of Novel Drug Approvals by U.S. FDA, by Drug Biologic Type, 2020-2024

Figure 22 : European Market Shares of Media, Sera and Reagents in Biotechnology, by Country, 2023

Figure 23 : Asia-Pacific Market Shares of Media, Sera and Reagents in Biotechnology, by Country, 2023

Figure 24 : Global Market Shares of Media, Sera and Reagents in Biotechnology, by Manufacturer/Supplier, 2023

Figure 25 : Advantages of ESG for the Companies in Cell Culture Media, Sera and Reagents

Figure 26 : BD: Revenue Shares, by Business Unit, FY 2024

Figure 27 : BD: Revenue Shares, by Country/Region, FY 2024

Figure 28 : Bio-Techne: Revenue Shares, by Business Unit, FY 2023

Figure 29 : Bio-Techne: Revenue Shares, by Country/Region, FY 2023

Figure 30 : Corning Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 31 : Corning Inc.: Revenue Shares, by Country/Region, FY 2023

Figure 32 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023

Figure 33 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023

Figure 34 : Lonza: Revenue Shares, by Business Unit, FY 2023

Figure 35 : Lonza: Revenue Shares, by Country/Region, FY 2023

Figure 36 : Merck KGaA: Revenue Shares, by Business Unit, FY 2023

Figure 37 : Merck KGaA: Revenue Shares, by Country/Region, FY 2023

Figure 38 : REPROCELL Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 39 : REPROCELL Inc.: Revenue Shares, by Country/Region, FY 2023

Figure 40 : Sartorius AG: Revenue Shares, by Business Unit, FY 2023

Figure 41 : Sartorius AG: Revenue Shares, by Country/Region, FY 2023

Figure 42 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 43 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• がん免疫療法の技術と世界市場 2025-04-17
• 再生可能エネルギーの技術と世界市場 2025-04-17
• 木材・プラスチック複合材の技術と世界市場 2025-04-17
• 先端材料の調査レビュー　2024年 2025-04-16
• コールドチェーンの地域別市場分析：中東＆北アフリカ 2025-04-16

BCC Research  出版レポート一覧